• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过在修饰剂存在的情况下测量底物反应来测定酶修饰的速率常数。

Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

作者信息

Tian W X, Tsou C L

出版信息

Biochemistry. 1982 Mar 2;21(5):1028-32. doi: 10.1021/bi00534a031.

DOI:10.1021/bi00534a031
PMID:7074045
Abstract

On the basis of the equations derived previously [Tsou, C. L. (1965) Sheng Wu Hua Hsueh Yu Sheng Wu Wu Li Hsueh Pao 5, 398-408, 409-417] for the substrate reaction during the course of enzyme modification, the kinetic behavior of the system chymotrypsin-substrate-modifier has been studied. The kinetics of benzoyltyrosine ester hydrolysis during the course of irreversible inhibition of the enzyme has been found to be in satisfactory agreement with equations obtained previously. The apparent rate constant between the enzyme and an irreversible inhibitor can be easily obtained in one single experiment by following the course of substrate hydrolysis in the presence of the inhibitor. The results are also in accord with the assumption that diisopropyl fluorophosphate can be classified as an irreversible competitive inhibitor. For both phenylmethanesulfonyl fluoride and L-1-[(p-toluene-sulfonyl)amino]-2-phenylethyl chloromethyl ketone, the inhibition has been found to be in agreement with the kinetics of the complexing type; i.e., a noncovalent enzyme-inhibitor complex is formed before irreversible enzyme modification. Both the equilibrium constants for the complex formation and the first-order rate constants for the irreversible modification step have been determined also by following the course of substrate hydrolysis in the presence of the irreversible inhibitor.

摘要

基于先前推导的方程[邹承鲁(1965年),《生物化学与生物物理学报》5, 398 - 408, 409 - 417],研究了在酶修饰过程中底物反应的情况,对胰凝乳蛋白酶 - 底物 - 修饰剂体系的动力学行为进行了研究。发现在酶的不可逆抑制过程中苯甲酰酪氨酸乙酯水解的动力学与先前得到的方程符合得很好。通过在抑制剂存在下跟踪底物水解过程,在单次实验中就能轻松得到酶与不可逆抑制剂之间的表观速率常数。结果也符合将氟磷酸二异丙酯归类为不可逆竞争性抑制剂的假设。对于苯甲磺酰氟和L - 1 - [(对甲苯磺酰基)氨基]-2 - 苯乙基氯甲基酮,已发现抑制作用符合络合类型的动力学;即,在酶进行不可逆修饰之前会形成非共价的酶 - 抑制剂复合物。通过在不可逆抑制剂存在下跟踪底物水解过程,还测定了复合物形成的平衡常数以及不可逆修饰步骤的一级速率常数。

相似文献

1
Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.通过在修饰剂存在的情况下测量底物反应来测定酶修饰的速率常数。
Biochemistry. 1982 Mar 2;21(5):1028-32. doi: 10.1021/bi00534a031.
2
Determination of rate constants for the irreversible inhibition of acetylcholine esterase by continuously monitoring the substrate reaction in the presence of the inhibitor.通过在抑制剂存在的情况下连续监测底物反应来测定乙酰胆碱酯酶不可逆抑制的速率常数。
Biochim Biophys Acta. 1986 Mar 28;870(2):185-90. doi: 10.1016/0167-4838(86)90220-7.
3
Inactivation of chymotrypsin and human skin chymase: kinetics of time-dependent inhibition in the presence of substrate.胰凝乳蛋白酶和人皮肤糜蛋白酶的失活:在底物存在下时间依赖性抑制的动力学
Biochim Biophys Acta. 1988 Apr 14;953(3):269-79. doi: 10.1016/0167-4838(88)90035-0.
4
Kinetics of substrate reaction during irreversible modification of enzyme activity for enzymes involving two substrates.涉及两种底物的酶活性不可逆修饰过程中底物反应的动力学
J Theor Biol. 1987 Aug 7;127(3):253-70. doi: 10.1016/s0022-5193(87)80106-6.
5
N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.N-[2,2-二甲基-3-(N-(4-氰基苯甲酰基)氨基)壬酰基]-L-苯丙氨酸乙酯作为一种胰凝乳蛋白酶样丝氨酸蛋白酶的稳定酯型抑制剂:有效抑制α-胰凝乳蛋白酶的结构要求。
J Med Chem. 1999 Jan 28;42(2):312-23. doi: 10.1021/jm980562h.
6
[pH-dependence of tryptophan ethyl ester hydrolysis by alpha-chymotrypsin].[α-胰凝乳蛋白酶催化色氨酸乙酯水解的pH依赖性]
Biokhimiia. 1980 Apr;45(4):629-35.
7
Kinetic investigation of the alpha-chymotrypsin-catalyzed hydrolysis of peptide-ester substrates. The relationship between the structure of the peptide moiety and reactivity.α-胰凝乳蛋白酶催化肽酯底物水解的动力学研究。肽部分结构与反应活性之间的关系。
Eur J Biochem. 1975 Oct 1;58(1):167-76. doi: 10.1111/j.1432-1033.1975.tb02361.x.
8
Design of peptide enzymes (pepzymes): surface-simulation synthetic peptides that mimic the chymotrypsin and trypsin active sites exhibit the activity and specificity of the respective enzyme.肽酶(pepzyme)的设计:模拟胰凝乳蛋白酶和胰蛋白酶活性位点的表面模拟合成肽表现出相应酶的活性和特异性。
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8282-6. doi: 10.1073/pnas.90.17.8282.
9
Kinetics of inactivation of aminoacylase by 2-chloromercuri-4-nitrophenol: a new type of complexing inhibitor.2-氯汞基-4-硝基苯酚对氨基酰化酶的失活动力学:一种新型络合抑制剂
Biochemistry. 1995 May 23;34(20):6863-8. doi: 10.1021/bi00020a033.
10
Kinetic differentiation between enzyme inactivation involving complex-formation with the inactivator and that involving a conformation-change step.涉及与失活剂形成复合物的酶失活和涉及构象变化步骤的酶失活之间的动力学差异。
Biochem J. 1992 Mar 1;282 ( Pt 2)(Pt 2):501-4. doi: 10.1042/bj2820501.

引用本文的文献

1
Advancing Covalent Ligand and Drug Discovery beyond Cysteine.超越半胱氨酸推进共价配体与药物发现
Chem Rev. 2025 Jul 23;125(14):6653-6684. doi: 10.1021/acs.chemrev.5c00001. Epub 2025 May 22.
2
A practical guide for the assay-dependent characterisation of irreversible inhibitors.不可逆抑制剂检测依赖性表征实用指南。
RSC Med Chem. 2024 Nov 1. doi: 10.1039/d4md00707g.
3
Fitting of and Values from Endpoint Pre-incubation IC Data.根据终点预孵育IC数据拟合 和 值。
ACS Med Chem Lett. 2024 Apr 4;15(5):731-738. doi: 10.1021/acsmedchemlett.4c00054. eCollection 2024 May 9.
4
High-Throughput Discovery and Characterization of Covalent Inhibitors for Protein Tyrosine Phosphatases.高通量发现和鉴定蛋白质酪氨酸磷酸酶的共价抑制剂。
Methods Mol Biol. 2024;2743:301-316. doi: 10.1007/978-1-0716-3569-8_19.
5
Novel inhibitors and activity-based probes targeting serine proteases.靶向丝氨酸蛋白酶的新型抑制剂及基于活性的探针
Front Chem. 2022 Sep 28;10:1006618. doi: 10.3389/fchem.2022.1006618. eCollection 2022.
6
Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.用于治疗非洲人类锥虫病的减少肽键拟肽迈克尔受体的开发。
Molecules. 2022 Jun 11;27(12):3765. doi: 10.3390/molecules27123765.
7
Structural, mechanistic, and physiological insights into phospholipase A-mediated membrane phospholipid degradation in .揭示磷脂酶 A 介导的细胞膜磷脂降解的结构、机制和生理学见解。
Elife. 2022 May 10;11:e72824. doi: 10.7554/eLife.72824.
8
Novel Inhibitors and Activity-Based Probes Targeting Trypsin-Like Serine Proteases.靶向类胰蛋白酶丝氨酸蛋白酶的新型抑制剂及基于活性的探针
Front Chem. 2022 Apr 21;10:782608. doi: 10.3389/fchem.2022.782608. eCollection 2022.
9
Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor.通过蛋白质-蛋白质相互作用破坏剂对锥虫硫醇还原酶的拟不可逆慢结合抑制作用。
Br J Pharmacol. 2020 Nov;177(22):5163-5176. doi: 10.1111/bph.15250. Epub 2020 Oct 2.
10
Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors.强效和选择性共价蛋白精氨酸甲基转移酶5(PRMT5)抑制剂的发现
ACS Med Chem Lett. 2019 May 22;10(7):1033-1038. doi: 10.1021/acsmedchemlett.9b00074. eCollection 2019 Jul 11.